How do patients with head and neck cancer and low skeletal muscle mass experience cisplatin-based chemoradiotherapy? A qualitative study

被引：0
|
作者：
Anouk W. M. A. Schaeffers [1 ]
Maartje A. van Beers [1 ]
Lot A. Devriese [2 ]
F. W. José Klomp [1 ]
Chantal F. M. Westerink - van den Brink [1 ]
Ernst J. Smid [3 ]
Remco de Bree [1 ]
Caroline M. Speksnijder [1 ]
机构：
[1] University Medical Center Utrecht,Department of Head and Neck Surgical Oncology
[2] Utrecht University,Department of Medical Oncology
[3] University Medical Center Utrecht,Department of Radiotherapy
[4] Utrecht University,Department of Oral and Maxillofacial Surgery and Special Dental Care
[5] University Medical Center Utrecht,undefined
[6] Utrecht University,undefined
[7] University Medical Center Utrecht,undefined
[8] Utrecht University,undefined
来源：
Supportive Care in Cancer | 2024年 / 32卷 / 11期
关键词：
Chemoradiation; Cisplatin; Skeletal muscle mass; Dose limiting toxicity; Head and neck cancer; Qualitative research;
D O I：
10.1007/s00520-024-08950-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy
    Chargi, Najiba
    Wegner, Inge
    Markazi, Navid
    Smid, Ernst
    de Jong, Pim
    Devriese, Lot
    de Bree, Remco
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [2] The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin-based chemoradiotherapy in patients with head and neck squamous cell carcinoma
    Schaeffers, Anouk W. M. A.
    Burger, Anouk V. M.
    Duinkerken, Charlotte W.
    van Sluis, Klaske E.
    de Boer, Jan Paul
    van der Molen, Lisette
    Hoetink, Alex E.
    Al-Mamgani, Abrahim
    Jozwiak, Katarzyna
    Devriese, Lot A.
    de Bree, Remco
    Zuur, Charlotte L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024,
  • [3] Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy
    Suzuki, Satoshi
    Yokota, Tomoya
    Notsu, Akifumi
    Hamauchi, Satoshi
    Onozawa, Yusuke
    Fushiki, Kunihiro
    Oshima, Kotoe
    Kawakami, Takeshi
    Tsushima, Takahiro
    Yasui, Hirofumi
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Kawatani, Keisuke
    Yamazaki, Kentaro
    ONCOLOGIST, 2024,
  • [4] The association of cisplatin pharmacokinetics and skeletal muscle mass in patients with head and neck cancer: The prospective PLATISMA study
    Chargi, Najiba
    Molenaar-Kuijsten, Laura
    Huiskamp, Laura F. J.
    Devriese, Lot A.
    de Bree, Remco
    Huitema, Alwin D. R.
    EUROPEAN JOURNAL OF CANCER, 2022, 160 : 92 - 99
  • [5] Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy
    Becker, Jan-Niklas
    Hermann, Robert
    Wichmann, Joern
    Sonnhoff, Mathias
    Christiansen, Hans
    Bruns, Frank
    PLOS ONE, 2023, 18 (02):
  • [6] Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol
    Schaeffers, Anouk W. M. A.
    Devriese, Lot A.
    van Gils, Carla H.
    Dankbaar, Jan Willem
    Voortman, Jens
    de Boer, Jan Paul
    Slingerland, Marije
    Hendriks, Mathijs P.
    Smid, Ernst J.
    Frederix, Geert W. J.
    de Bree, Remco
    PLOS ONE, 2023, 18 (11):
  • [7] The association of skeletal muscle mass and cisplatin pharmacokinetics in head and neck cancer patients: The prospective PLATISMA study.
    Molenaar-Kuijsten, Laura
    Chargi, Najiba
    Devriese, Lot
    de Bree, Remco
    Huitema, Alwin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients
    C. D. A. Meerkerk
    N. Chargi
    P. A. de Jong
    F. van den Bos
    R. de Bree
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 967 - 977
  • [9] Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients
    Meerkerk, C. D. A.
    Chargi, N.
    de Jong, P. A.
    van den Bos, F.
    de Bree, R.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (02) : 967 - 977
  • [10] Accelerated loss of lean body mass in head and neck cancer patients during cisplatin-based chemoradiation
    Lonbro, Simon
    Gam, Soren
    Hermann, Anne Pernille
    Hansen, Christian Ronn
    Johansen, Jorgen
    ACTA ONCOLOGICA, 2023, 62 (11) : 1403 - 1411
12345